Scarlett Okerblom
Medical · Santa Maria, CANPI 1467804880
Payments from drug & device makers
Across 205 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$817
- Amgen$677
- Pfizer$502
- GSK$451
- Novartis$272
- Bayer$100
- plus $447 from 14 others
What the payments were for
- Food & beverage$3,267100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $817 |
| Amgen | 48 | $677 |
| Pfizer | 31 | $502 |
| GSK | 42 | $451 |
| Novartis | 10 | $272 |
| Bayer | 5 | $100 |
| Novo Nordisk | 5 | $87 |
| Biohaven Pharmaceuticals, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $44 |
| Biosense Webster, Inc. | 1 | $43 |
| Astellas Pharma US Inc | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Medtronic | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$3,267 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 67 | $72,437 |
| OzempicSemaglutide | 37 | $42,140 |
| EliquisApixaban | 40 | $38,625 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 26 | $26,329 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $23,327 |
| FarxigaDapagliflozin Propanediol | 15 | $20,013 |
| TrulicityDulaglutide | 20 | $18,528 |
| Repatha SureclickEvolocumab | 25 | $16,361 |
| Ezetimibe | 214 | $8,062 |
| BelsomraSuvorexant | 12 | $5,142 |
| Rosuvastatin Calcium | 156 | $4,073 |
| Atorvastatin Calcium | 218 | $2,249 |
| Levothyroxine Sodium | 110 | $1,991 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $1,922 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $1,606 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $18 | $72,43767 claims |
| Novo NordiskOzempic | $87 | $42,14037 claims |
| PfizerEliquis | $502 | $38,62540 claims |
| GSKTrelegy Ellipta | $451 | $23,32729 claims |
| Lilly USA, LLCTrulicity | $44 | $18,52820 claims |
| AbbVieSynthroid | $817 | $65711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 medical providers in California.
Other medical in Santa Maria
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.